Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

TAKAAKI FUJII; JUN HORIGUCHI; YASUHIRO YANAGITA; YUKIO KOIBUCHI; FUMIHIRO IKEDA; NOBUYUKI UCHIDA; MORIHIKO KIMURA; GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG)

Research ArticleClinical Studies

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

TAKAAKI FUJII, JUN HORIGUCHI, YASUHIRO YANAGITA, YUKIO KOIBUCHI, FUMIHIRO IKEDA, NOBUYUKI UCHIDA, MORIHIKO KIMURA and GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG)

Anticancer Research February 2018, 38 (2) 905-909;

TAKAAKI FUJII

1Division of Breast and Endocrine Surgery, Department of General Surgical Science, Graduate School of Medicine, Gunma University, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: ftakaaki@gunma-u.ac.jp

JUN HORIGUCHI

2Breast Surgery, International University of Health and Welfare, Chiba, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YASUHIRO YANAGITA

3Department of Breast Oncology, Gunma Prefectural Cancer Center, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

YUKIO KOIBUCHI

4Breast and Endocrine Surgery, NHO Takasaki General Medical Center, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

FUMIHIRO IKEDA

5Breast and Endocrine Surgery, Maebashi Red Cross Hospital, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

NOBUYUKI UCHIDA

6Surgery, Haramachi Red Cross Hospital, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MORIHIKO KIMURA

7Breast Surgery, Ota Memorial Hospital, Gunma, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Kaplan–Meier estimates of progression-free (a) and overall survival (b) rates. Bars represent patients whose data were censored.

Tables

Figures

PreviousNext

In this issue

Anticancer Research

Vol. 38, Issue 2

February 2018

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 6 + 11 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

TAKAAKI FUJII, JUN HORIGUCHI, YASUHIRO YANAGITA, YUKIO KOIBUCHI, FUMIHIRO IKEDA, NOBUYUKI UCHIDA, MORIHIKO KIMURA, GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG)

Anticancer Research Feb 2018, 38 (2) 905-909;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

TAKAAKI FUJII, JUN HORIGUCHI, YASUHIRO YANAGITA, YUKIO KOIBUCHI, FUMIHIRO IKEDA, NOBUYUKI UCHIDA, MORIHIKO KIMURA, GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG)

Anticancer Research Feb 2018, 38 (2) 905-909;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Characteristics of Patients With Metastatic Breast Cancer Who Survived more than 10 Years
Pilot Study of Irinotecan and S-1 (IRIS) for Advanced and Metastatic Breast Cancer
Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer

Google Scholar

Keywords

HER2-positive breast cancer
S-1
trastuzumab

Main menu

User menu

Search

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01)

Article Figures & Data

Figures

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords